Biosimilars in 2020

Biosimilar Development |

Rick Lozano, VP of Biosimilars & Specialty Blood Products at AmerisourceBergen, shares his insight with Biosimilar Development and explains why 2019 was a historic year for the biosimilar channel and how 2020 will introduce a new era of competition and access for the market.